| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Rabbit |
| Applications | ELISA,ChIP,ChIP-Seq |
| Brand: | Abnova |
| Reference: | PAB31305 |
| Product name: | RUNX1T1 polyclonal antibody |
| Product description: | Rabbit polyclonal antibody raised against synthetic peptide of RUNX1T1. |
| Gene id: | 862 |
| Gene name: | RUNX1T1 |
| Gene alias: | AML1T1|CBFA2T1|CDR|ETO|MGC2796|MTG8|MTG8b|ZMYND2 |
| Gene description: | runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
| Immunogen: | A synthetic peptide (conjugated with KLH) corresponding to N-terminus and the central region of human RUNX1T1. |
| Protein accession: | Q06455 |
| Form: | Liquid |
| Recommend dilutions: | ELISA (1:100) ChIP (4 ug/ChIP) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In whole antiserum (0.05% sodium azide). |
| Storage instruction: | Store at -20°C. For long term storage store at -80°C. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Tag: | KLH |
| Product type: | Primary antibodies |
| Host species: | Rabbit |
| Antigen species / target species: | Human |
| Reactivity: | Human |
| Application image: | ![]() |
| Application image note: | ChIP assays were performed using SKNO-1 cells. Sheared chromatin from 1.25 million cells and 4 ul of antibody were used per ChIP experiment. QPCR was performed using primers specific for the FUT7, NFE2, OGG1 and VEGF genes. The figure shows the occupancy, calculated as the ratio + control/background for which the H2B gene was used. |
| Applications: | ELISA,ChIP,ChIP-Seq |
| Shipping condition: | Dry Ice |
| Publications: | ERG and FLI1 binding sites demarcate targets for aberrant epigenetic regulation by AML1-ETO in acute myeloid leukemia.Martens JH, Mandoli A, Simmer F, Wierenga BJ, Saeed S, Singh AA, Altucci L, Vellenga E, Stunnenberg HG. Blood. 2012 Nov 8;120(19):4038-48. |